Lexaria Bioscience Corp (LEXX)

$0.73 +0.02 (3.17%)
Market Cap 17.42M
Revenue (ttm) 710,000.00
Net Income (ttm) -11.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,676.06%
Debt to Equity Ratio 0.00
Volume 113,500
Avg Vol 198,412
Day's Range N/A - N/A
Shares Out 24.89M
Stochastic %K 27%
Beta 0.54
Analysts Strong Sell
Price Target $4.50

Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is...

Industry: Biotechnology
Sector: Healthcare
Phone: 250 765 6424
Address:
740 McCurdy Road, Suite 100, Kelowna, Canada
hovian
hovian Mar. 18 at 12:40 AM
$LEXX make me think a that kind of women...lexx do it, humm yes...not...maybe...okay...later....yes why not....later....now...yessss...but not yet...
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 11:56 PM
$LEXX Should boom tomorrow and rest of the week 💣 🧨 Daily RSI cross - MACD expanding - looking like a MACD centreline cross tomorrow. Closed above the 50 day moving average - next test is closing above the 100 day at 84c. https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=LEXX
0 · Reply
cashonthebarrelhead
cashonthebarrelhead Mar. 17 at 9:27 PM
$LEXX Everyone need to email and complain to Schwab for not letting you buy on line. Its total bs. They will take your shares in a heartbeat if you sell online, but to buy you have to call it in to broker on phone .
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 7:08 PM
$LEXX Couple wankers hanging out on the ask, they will get cleared out soon 😜
0 · Reply
ahuegen
ahuegen Mar. 17 at 7:00 PM
$LEXX Filled with 0,75 and ,7599 while had a limit order at ,78 Seems still shares available and MM not stepping inbetween Regards from Germany
0 · Reply
ahuegen
ahuegen Mar. 17 at 6:58 PM
$LEXX Another 7.000 @ ,78 only 6k filled 1k open
0 · Reply
Turbofueled
Turbofueled Mar. 17 at 6:37 PM
$LEXX Have Faith!! Its Coming!!
0 · Reply
Shubeedoo
Shubeedoo Mar. 17 at 6:28 PM
$LEXX Volume is still very light, sniffing out sellers, but someone wants this
0 · Reply
Boston7452
Boston7452 Mar. 17 at 6:24 PM
$LEXX Volume seems too light no?
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 6:08 PM
$LEXX Come on let’s just get a little rally to $1.20 going … 2025 funding was done at $1.31 avg and we could be on the one yard line to transformational news… Seems worthy of a 60% afternoon to me $
0 · Reply
Latest News on LEXX
Lexaria Announces New R&D Plans for 2026

Mar 4, 2026, 9:25 AM EST - 13 days ago

Lexaria Announces New R&D Plans for 2026

LEXX

Lexaria Announces Positive Final Results From Human Pilot Study #5

Feb 5, 2026, 9:15 AM EST - 5 weeks ago

Lexaria Announces Positive Final Results From Human Pilot Study #5

LEXX

Lexaria Awarded Six Additional Patents

Jan 22, 2026, 9:20 AM EST - 7 weeks ago

Lexaria Awarded Six Additional Patents

LEXX

Lexaria Releases Annual Letter from the CEO

Jan 12, 2026, 9:10 AM EST - 2 months ago

Lexaria Releases Annual Letter from the CEO

LEXX

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

Dec 30, 2025, 9:20 AM EST - 2 months ago

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

LEXX

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

Dec 23, 2025, 12:06 PM EST - 3 months ago

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

NVO LEXX

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4

Dec 23, 2025, 9:29 AM EST - 3 months ago

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4

LEXX

Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 16, 2025, 4:00 PM EST - 3 months ago

Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LEXX

Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 15, 2025, 8:00 AM EST - 3 months ago

Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LEXX

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

Nov 12, 2025, 9:10 AM EST - 4 months ago

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

LEXX

Lexaria Bioscience Corp. Provides Strategic Update

Oct 9, 2025, 9:20 AM EDT - 5 months ago

Lexaria Bioscience Corp. Provides Strategic Update

LEXX

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 29, 2025, 4:30 PM EDT - 6 months ago

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LEXX

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 26, 2025, 8:10 AM EDT - 6 months ago

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LEXX

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Sep 19, 2025, 11:20 AM EDT - 6 months ago

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

LEXX

Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference

Aug 27, 2025, 9:20 AM EDT - 7 months ago

Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference

LEXX

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

Aug 14, 2025, 9:20 AM EDT - 7 months ago

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

LEXX

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

Aug 6, 2025, 9:20 AM EDT - 7 months ago

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

LEXX

Lexaria Provides Positive Interim Results on Partial 8-week Data From Phase 1b, GLP-1-H24-4 Study

Jul 28, 2025, 9:25 AM EDT - 8 months ago

Lexaria Provides Positive Interim Results on Partial 8-week Data From Phase 1b, GLP-1-H24-4 Study

LEXX

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

Jul 28, 2025, 9:25 AM EDT - 8 months ago

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

LEXX

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

Jul 23, 2025, 9:25 AM EDT - 8 months ago

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

LEXX

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

Jun 23, 2025, 9:15 AM EDT - 9 months ago

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

LEXX

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

Jun 11, 2025, 9:05 AM EDT - 9 months ago

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

LEXX

Lexaria Attending BIO International Convention

Jun 5, 2025, 9:20 AM EDT - 10 months ago

Lexaria Attending BIO International Convention

LEXX

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

May 12, 2025, 9:00 AM EDT - 11 months ago

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

LEXX

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

Apr 28, 2025, 4:15 PM EDT - 11 months ago

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

LEXX

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

Apr 25, 2025, 8:00 AM EDT - 11 months ago

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

LEXX

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology

Apr 23, 2025, 9:10 AM EDT - 11 months ago

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology

LEXX

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Apr 3, 2025, 9:10 AM EDT - 1 year ago

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

LEXX

Lexaria's Human GLP-1 Study #5 Begins Dosing

Apr 2, 2025, 9:05 AM EDT - 1 year ago

Lexaria's Human GLP-1 Study #5 Begins Dosing

LEXX

Lexarias' DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound

Mar 18, 2025, 9:15 AM EDT - 1 year ago

Lexarias' DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound

LEXX

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)

Mar 18, 2025, 9:15 AM EDT - 1 year ago

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)

LEXX

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

Feb 27, 2025, 8:00 AM EST - 1 year ago

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

LEXX

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

Feb 24, 2025, 8:00 AM EST - 1 year ago

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

LEXX

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

Feb 20, 2025, 8:00 AM EST - 1 year ago

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

LEXX

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

Feb 11, 2025, 8:00 AM EST - 1 year ago

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

LEXX

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

Feb 6, 2025, 9:40 AM EST - 1 year ago

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

LEXX

Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval

Jan 15, 2025, 9:20 AM EST - 1 year ago

Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval

LEXX

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

Jan 14, 2025, 9:10 AM EST - 1 year ago

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

LEXX

Lexaria's Registered GLP-1 Study #4 Begins Dosing

Dec 19, 2024, 9:05 AM EST - 1 year ago

Lexaria's Registered GLP-1 Study #4 Begins Dosing

LEXX

Lexaria Forms New Scientific Advisory Board

Dec 18, 2024, 9:25 AM EST - 1 year ago

Lexaria Forms New Scientific Advisory Board

LEXX

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

Dec 17, 2024, 9:10 AM EST - 1 year ago

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

LEXX

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Dec 9, 2024, 9:10 AM EST - 1 year ago

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

LEXX

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

Nov 26, 2024, 9:20 AM EST - 1 year ago

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

LEXX

Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

Nov 25, 2024, 9:00 AM EST - 1 year ago

Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

LEXX

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study

Nov 20, 2024, 9:05 AM EST - 1 year ago

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study

LEXX

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

Nov 14, 2024, 9:10 AM EST - 1 year ago

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

LEXX

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

Nov 13, 2024, 9:20 AM EST - 1 year ago

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

LEXX

Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments

Nov 7, 2024, 9:15 AM EST - 1 year ago

Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments

LEXX

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

Oct 24, 2024, 9:10 AM EDT - 1 year ago

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

LEXX

Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

Oct 22, 2024, 9:20 AM EDT - 1 year ago

Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study

LEXX

hovian
hovian Mar. 18 at 12:40 AM
$LEXX make me think a that kind of women...lexx do it, humm yes...not...maybe...okay...later....yes why not....later....now...yessss...but not yet...
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 11:56 PM
$LEXX Should boom tomorrow and rest of the week 💣 🧨 Daily RSI cross - MACD expanding - looking like a MACD centreline cross tomorrow. Closed above the 50 day moving average - next test is closing above the 100 day at 84c. https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=LEXX
0 · Reply
cashonthebarrelhead
cashonthebarrelhead Mar. 17 at 9:27 PM
$LEXX Everyone need to email and complain to Schwab for not letting you buy on line. Its total bs. They will take your shares in a heartbeat if you sell online, but to buy you have to call it in to broker on phone .
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 7:08 PM
$LEXX Couple wankers hanging out on the ask, they will get cleared out soon 😜
0 · Reply
ahuegen
ahuegen Mar. 17 at 7:00 PM
$LEXX Filled with 0,75 and ,7599 while had a limit order at ,78 Seems still shares available and MM not stepping inbetween Regards from Germany
0 · Reply
ahuegen
ahuegen Mar. 17 at 6:58 PM
$LEXX Another 7.000 @ ,78 only 6k filled 1k open
0 · Reply
Turbofueled
Turbofueled Mar. 17 at 6:37 PM
$LEXX Have Faith!! Its Coming!!
0 · Reply
Shubeedoo
Shubeedoo Mar. 17 at 6:28 PM
$LEXX Volume is still very light, sniffing out sellers, but someone wants this
0 · Reply
Boston7452
Boston7452 Mar. 17 at 6:24 PM
$LEXX Volume seems too light no?
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 6:08 PM
$LEXX Come on let’s just get a little rally to $1.20 going … 2025 funding was done at $1.31 avg and we could be on the one yard line to transformational news… Seems worthy of a 60% afternoon to me $
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 6:01 PM
$LEXX Shorts still covering
0 · Reply
hovian
hovian Mar. 17 at 5:50 PM
$LEXX selling is NOT
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 5:39 PM
$LEXX Yeeehaw - the rally is on gents. Maybe mid 80s close
1 · Reply
AltradoLinguini
AltradoLinguini Mar. 17 at 5:35 PM
$LEXX I think, I mean I’m pretty sure that…yeah, I can come to terms with a 500%+ gain :)
1 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 5:26 PM
$LEXX She’s going up 🚀 @topstockalerts
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 5:25 PM
$LEXX Push engaged - loading 🧨🔋
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 5:23 PM
$LEXX Should I fuck with him and push it?
0 · Reply
Shubeedoo
Shubeedoo Mar. 17 at 5:22 PM
$LEXX Must be a seller hanging around and/or any buyers are in no hurry. Need something juicy with some meat on it, surprise us LEXX. And a reverse split would not be considered a surprise
0 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 5:20 PM
$LEXX About to explode - they are covering their short position. You can see it with the tiny buys
1 · Reply
hovian
hovian Mar. 17 at 4:50 PM
$LEXX 73 dollars traded innlast hour... wtf?
1 · Reply
Makingmillions192
Makingmillions192 Mar. 17 at 3:12 PM
$LEXX it will be there soon 10x
0 · Reply
Shubeedoo
Shubeedoo Mar. 17 at 2:55 PM
$LEXX Based on the volume, something must be close 😜
0 · Reply